Earnouts in M&A: Risk allocation, incentives, and post-closing disputes
He examines a recent Delaware Supreme Court case between Johnson & Johnson and Auris Health, Inc., illustrating how courts would uphold the negotiated terms of...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
With more than 50 years of experience in international arbitration, we are recognized for our clear and compelling presentation of expert findings. Our creative and multidisciplinary approaches pair our world-class industry knowledge with deep economic and forensic expertise. We work with clients on pre-dispute quantum and investigations, post dispute asset tracing and enforcement investigations, and providing superior quantum support and testimony.
Clients rely on us to demonstrate the complex issues and critical nuances of their case in an effective and persuasive manner. We have acted on over $100 billion worth of cases across all major tribunals including AAA, CRCICA, DIAC, DIFC-LIA, ICC, ICDR, ICSID, JAMS, LCIA, NAFTA, PCA, SCC, UNCITRAL and ZCC.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comVice President, Practice Leader of Intellectual Property
Chicago
+1-312-377-2279 dmcgavock@crai.comHe examines a recent Delaware Supreme Court case between Johnson & Johnson and Auris Health, Inc., illustrating how courts would uphold the negotiated terms of...
The refund question sits at the intersection of customs procedure, administrative law, but also economics, and resolution will likely vary significantly across...
Tiago Duarte-Silva is a panelist during the session titled “Parallel Proceedings and Emerging Liability Risks.” Managing risk on complex projects involves...
CRA is a proud sponsor of the lunch program which includes a moderated discussion with two leading arbitrators on how parties and advocates can more...








